Treatment Options for Heavy Irregular Periods in a 36-Year-Old Woman
First-line medical treatment should be either a levonorgestrel-releasing intrauterine device (LNG-IUD) or combined hormonal contraceptives, as these are the most effective options recommended by ACOG for managing abnormal uterine bleeding associated with ovulatory dysfunction. 1
Initial Evaluation Required
Before initiating any treatment, you must rule out underlying pathology:
- Pregnancy testing is mandatory 2
- Assess for structural causes including polyps, fibroids, adenomyosis, and endometrial pathology 1
- Check thyroid function and prolactin levels to exclude endocrine causes 1
- Consider endometrial biopsy if she has risk factors for endometrial cancer (though at age 36, this is primarily indicated if she has recurrent anovulation or other risk factors) 3
- Transvaginal ultrasound is the first-line imaging modality to evaluate for structural abnormalities 1, 4
Medical Treatment Options (Ranked by Effectiveness)
Most Effective: Levonorgestrel-Releasing IUD (LNG-IUD)
- The LNG-IUD reduces menstrual blood loss by 71-95%, making it the most effective long-term medical treatment 5
- Over time, many women experience only light bleeding or amenorrhea 5
- Effectiveness is comparable to endometrial ablation or hysterectomy 6
- This should be your first choice if she desires contraception or is open to an IUD 3, 4
Highly Effective: Combined Hormonal Contraceptives (CHCs)
- ACOG specifically recommends combined hormonal contraceptives (pills, patch, or ring) as first-line treatment for abnormal uterine bleeding with ovulatory dysfunction 1
- These regulate menstrual cycles and reduce bleeding 1
- Can be used continuously or cyclically depending on patient preference 1
Alternative Medical Options
Tranexamic Acid:
- Reduces menstrual blood loss by approximately 80 mL/cycle (about 50% reduction) 2
- Particularly useful when hormonal contraception is contraindicated or pregnancy is desired soon 4
- Critical contraindication: Do not use if she has any history of thrombosis or thromboembolic disease 2
- More expensive than other options 3
NSAIDs (Mefenamic Acid or Ibuprofen):
- Reduce menstrual blood loss by 20-50% 6, 4
- Use for 5-7 days during menstruation 1, 5
- Less effective than LNG-IUD or tranexamic acid but useful as adjunctive therapy 5
- Avoid in women with cardiovascular disease due to MI risk 5
Progestin-Only Contraception:
- Oral progestins for 21 days per month can regulate cycles 1, 3
- Less effective than LNG-IUD but an option if other methods are contraindicated 4
Surgical Options (Second-Line)
If medical treatment fails, is contraindicated, or not tolerated after adequate trial:
Endometrial Ablation:
- Effective for reducing bleeding when medical management fails 1, 2
- Less effective if fibroids or adenomyosis are present 2
- Preserves the uterus but future pregnancy is contraindicated 4
Hysterectomy:
- Most definitive treatment with complete resolution of bleeding 2, 3
- Reserved for failed medical/conservative surgical management 1, 4
- Should be performed vaginally or laparoscopically rather than abdominally 4
Practical Algorithm
Rule out pregnancy, structural pathology, and endocrine causes with exam, ultrasound, and labs 1, 2
Start with LNG-IUD if she's open to it - highest efficacy for long-term management 5, 4
If she prefers oral medication or needs immediate treatment, use combined hormonal contraceptives 1
If hormones are contraindicated, use tranexamic acid (if no thrombosis risk) 2, 4
If medical treatment fails after 3-6 months, consider endometrial ablation 1, 4
Reserve hysterectomy for failed conservative management 1, 4
Critical Pitfalls to Avoid
- Do not use cyclic progestins alone in ovulating women - they are ineffective for reducing menstrual blood loss 6
- Avoid aspirin - it may increase bleeding 5
- Screen for von Willebrand disease if she has had heavy periods since menarche, as coagulation disorders are commonly missed 3
- Do not skip endometrial assessment if she has risk factors for endometrial cancer or if bleeding persists despite treatment 1, 3